ChrysCapital, an investment firm that focuses on growth sectors in India, has raised its stake in India-listed pharmaceutical manufacturer Ipca Laboratories by buying an additional 1.3 percent stake for around US$20 million. The purchase took place through open market transactions over the last few months. ChrysCapital had previously acquired a 2.6 percent stake in Ipca Laboratories for approximately US$29 million two years ago.